Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-09-06-Speech-4-105"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2001-09-06"^^xsd:date2
dcterms:Is Part Of	lp_eu:VOTE2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20010906.5.4-105"2
lpv:hasSubsequent	lp_eu:2001-09-06-Speech-4-1062
lpv:speaker	lp:Gérard Caudron2
lpv:spokenAs	member; Delegation to the EU-Poland Joint Parliamentary Committee (1999-10-06--2002-01-14)3 unknown; Parti socialiste (1999-07-20--2002-07-09)3 member; Temporary committee on human genetics and other new technologies in modern medicine (2000-12-13--2001-11-29)3 member; Committee on Industry, External Trade, Research and Energy (1999-07-21--2002-01-14)3 substitute; Delegation to the EU-Cyprus Joint Parliamentary Committee (1999-10-08--2002-01-14)3 substitute; Committee on Foreign Affairs, Human Rights, Common Security and Defence Policy (1999-07-22--2002-01-14)3 member_of_the_bureau; PES (1999-07-20--2002-01-16)3
lpv:translated text	". I, like many of my colleagues, have heard from blood donation organisations concerned by the possible modifications to existing legislation in this field. Everyone agrees in deploring, quite rightly, the shortage of blood and plasma within the European Union while stressing the fact that under no circumstances should we relax our vigilance regarding the quality of these products, so much so that the European Union’s requirements are half covered by imports! This directive, amended by Parliament, modifies, integrates and completes the legislation that currently governs quality and safety standards in Europe for the collection, testing, processing, storage and distribution of human blood and blood components. It is about adopting stricter requirements regarding the admissibility of donors and practical screening of them, as well as putting in place a quality system at Community level in blood transfusion establishments. This would all be completed by an equivalent testing and approval system in the Member States. Finally, common standards would be defined for staff training and for the traceability of blood from donor to patient. Of course, these measures will not prevent the Member States from maintaining or establishing stricter protection measures. It is also desirable to reduce the European Union’s dependence on imports of blood or blood components from third countries. In order to do that, information campaigns need to be aimed at potential donors. But under no circumstances should we envisage a system of payment for these products. The European Parliament report rightly stresses the importance of the voluntary nature of blood donation while accepting that the social contribution made by donors and the commendable nature of the donations that they make should be highlighted. As a blood donor myself and a supporter of the cause of blood donation, I therefore voted in favour of this report."@en1
lpv:unclassifiedMetadata	"Caudron (PSE ),"1 "in writing"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph